Sigma-Aldrich to Acquire
Proligo; Shelves India Facility
Sigma-Aldrich plans to purchase DNA and RNA maker Proligo from Degussa, the company said this week.
Proligo, headquartered in Boulder, Colo., provides custom DNA, RNA, and raw materials for DNA and RNA synthesis. The company is one of four exclusive licensees to an RNAi patent application owned by MIT.
Last year, Proligo had approximately $40 million in sales. The 300-employee company has manufacturing sites in Boulder, France, Germany, Singapore, Japan, and Australia.